American Vanguard (AVD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
23 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 3, 2026, with voting on director elections, auditor ratification, say-on-pay, and say-on-pay frequency proposals.
Seven directors are nominated, with board size reduced from nine to seven per new credit agreement requirements.
Deloitte & Touche LLP is recommended for reappointment as independent auditor for 2026.
Executive compensation is benchmarked against peers, with a pay-for-performance philosophy and significant alignment to company KPIs.
No related party transactions occurred in 2025.
Voting matters and shareholder proposals
Proposals include election of seven directors, auditor ratification, advisory vote on executive compensation, and advisory vote on frequency of say-on-pay.
Board recommends annual say-on-pay votes and approval of executive compensation.
No other business or shareholder proposals were submitted by the deadline.
Board of directors and corporate governance
Board size set at seven, with three directors not seeking reelection and one new independent nominee added per lender requirements.
Board committees include Audit, Compensation, Nominating & Corporate Governance, Finance, Risk, and a pro-tem Transaction Committee.
Five of seven director nominees are independent under NYSE standards.
Board met 15 times in 2025; all directors attended at least 75% of meetings.
Latest events from American Vanguard
- 2025 margins improved and losses narrowed; 2026 targets higher EBITDA and growth from new products.AVD
Q4 202516 Mar 2026 - Q2 sales and margins fell, guidance was cut, and transformation and cost-saving efforts accelerated.AVD
Q2 20242 Feb 2026 - Q3 loss and sales drop driven by recall, but guidance and non-crop growth remain strong.AVD
Q3 202415 Jan 2026 - Transformation plan aims for 15% EBITDA margin and growth in biologicals by 2025.AVD
Gabelli Funds' 16th Annual Specialty Chemicals Symposium26 Dec 2025 - 2024 EBITDA met guidance as debt and inventory fell; 2025 targets higher revenue and margin.AVD
Q4 202424 Dec 2025 - Virtual meeting to elect directors, ratify auditor, and approve performance-based executive pay.AVD
Proxy Filing2 Dec 2025 - Adjusted EBITDA up 350%, gross margin 29%, and net loss narrowed on strong U.S. crop sales.AVD
Q3 202517 Nov 2025 - Q1 sales dropped 14% with a net loss, but cost cuts and lower debt support recovery.AVD
Q1 202514 Nov 2025 - Adjusted EBITDA nearly doubled and gross margin hit a five-quarter high as net loss narrowed.AVD
Q2 20257 Aug 2025